StratDeck

Two stocks in Healthcare

Bristol-Myers Squibb vs Thermo Fisher Scientific: profit, growth, debt and price compared

Thermo Fisher Scientific is stronger on 4 of 7 figures: sales growth, debt, analysts' view and price trend. Bristol-Myers Squibb is stronger on 3: profit margin, price for its expected profit and dividend.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore Bristol-Myers Squibb's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Bristol-Myers Squibb and Thermo Fisher Scientific side by side
Bristol-Myers SquibbBMYThermo Fisher ScientificTMO
Net marginStronger: 18.5%14.9%
Revenue growth, past year+6.93%Stronger: +9.13%
Debt to equity191.5%Stronger: 75.4%
Forward P/EStronger: 8.9×24.9×
Dividend yieldStronger: 4.23%0.27%
AnalystsBuy · 24Stronger: Strong buy · 25
From its 200-day average+1.2%Stronger: +17.3%

Share price over the past year

  • Bristol-Myers Squibb+26.6%
  • Thermo Fisher Scientific+20.3%

18 Nov 202518 Nov 2026

Bristol-Myers Squibb or Thermo Fisher Scientific: which is stronger?

  • BMY

    Which is more profitable?

    Bristol-Myers Squibb keeps more of each sale as profit: 18.5% against 14.9%.

  • TMO

    Which is growing its sales faster?

    Thermo Fisher Scientific is growing its sales faster: +9.13% over the past year, against +6.93%.

  • TMO

    Which has borrowed less?

    Thermo Fisher Scientific has borrowed less: its debt is 75.4% of what its shareholders own, against 191.5% for Bristol-Myers Squibb.

  • BMY

    Which costs less for the profit it is expected to make?

    Bristol-Myers Squibb costs less for the profit it is expected to make: 8.9× its forward earnings, against 24.9×.

  • BMY

    Which pays more in dividends?

    Bristol-Myers Squibb pays more back in dividends for what a share costs: 4.23% a year, against 0.27%.

  • TMO

    Which do analysts rate higher?

    Analysts are warmer on Thermo Fisher Scientific: Strong buy, against Buy for Bristol-Myers Squibb.

  • TMO

    Which is in the stronger price trend?

    Thermo Fisher Scientific's price is in the stronger trend: 17.3% above its 200-day average, against 1.2% above.

What each company does

BMYBristol-Myers Squibb

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Reports results on 4 February 2027

TMOThermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally.

Reports results on 28 January 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.